SAB Biotherapeutics

SAB Biotherapeutics is going public as it continues testing its COVID-19 treatment.

More money is flowing to a South Dakota company that hopes to create a treatment for COVID-19.SAB Biotherapeutics in Sioux Falls is getting $57.5 million…

In The Moment ... August 21, 2020 Show 886 Hour 1SAB Biotherapeutics in Sioux Falls announced the first step in its trial of a COVID 19 therapeutic…

A South Dakota company is working on a therapeutic to treat COVID 19 – the disease caused by the coronavirus. S-A-B Biotherapeutics has been working on…

Blaine Crissman is with South Dakota Equity Partners and Eddie Sullivan is with SAB Biotherapeutics. SAB Biotherapeutics is a clinical-stage…

Eddie Sulivan, SAB Biotherapeutics president and CEO, joined Innovation to discuss the recent advancements made by his company.SAB Biotherapeutics…

In The Moment ... June 8, 2018 Show 354 Hour 2The USD Discovery District has its first anchor tenant - SAB Biotherapeutics, Inc. SAB president, CEO and…

Ag Innovation is the focus of a panel conversation during the Governor’s Ag Summit in Aberdeen. Other topics include animal health, economics and…

Eddie Sullivan is the President, CEO and Co-Founder of SAB Biotherapeutics, Inc. based in Sioux Falls. The biopharmaceutical company leads the science and…